An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.
A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...
Ir-Vax is under clinical development by ImmunoRestoration and currently in Phase I for Triple-Negative Breast Cancer (TNBC).
Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.